The concept of stimulating the response of the body’s immune system is the basis for the vaccination. Vaccines respond by facilitating the effect of the innate immune response and activating the antigen presenting calls (APCs), thereby stimulating the protective immune response to the pathogen antigens. Adjuvants are the substances that are added to the vaccines to enhance the immunological effect of extremely purified antigens that have sufficient immunostimualtory capabilities, and have been used in vaccines for many decades. Adjuvants helps vaccine work better. Some of the vaccines contain dead or weakened microbes and stimulate the produce a strong immune response. However, most of the vaccines todays contain small components of microbes such as, proteins instead of entire microbe. These vaccines must include adjuvants to ensure that body produce strong enough immune response that he does not need to be vaccinated again.
Vaccine Adjuvants Market: Drivers and Restraints
Vaccines adjuvants market is expected to be driven by increasing prevalence of conditions such as, allergy, HIV and cancer. Vaccine adjuvants market also expected to be fueled by increasing demand for the advanced treatment options and development of vaccines with improved immunization. Other factors which are also boosting the growth of vaccine adjuvants market are increasing geriatric population and prevalence of infections.
Vaccine Adjuvants Market: Segmentation
The global vaccine adjuvants market can be segmented on the basis of product type, route of administration, application category, end user and region.
On the basis of product type the global vaccine adjuvants market can be segmented into:
On the basis of route of administration the global vaccine adjuvants market can be segmented into:
On the basis of application category the global vaccine adjuvants market can be segmented into:
On the basis of end use the global vaccine adjuvants market can be segmented into:
Vaccine Adjuvants Market: Overview
The global vaccine adjuvants market is expected to grow significantly over the forecast period. Advanced vaccines are being developed that do not contain dead or weakened microbes but contain a part of microbes. These vaccines require adjuvants to produce a strong immunological response to the antigens administered. Particulate adjuvants segment is biggest product segment if the global vaccine adjuvants market. Because, these particles are capable of producing the strong immune response and also enhance the delivery of antigen to immune system. Combination adjuvants segment is expected to be fastest growing segment because these adjuvants have ability to stimulate the multiple protective immune response. Intramuscular vaccine segment is expected to be the largest segment of global vaccine adjuvants market over the forecast period. As this route of administration is most effective and fastest route. Other factor driving the growth of vaccines adjuvants market increasing demand for the specific and advanced treatment options.
Vaccine Adjuvants Market: Region Wise Outlook
Geographically, the global vaccine adjuvants market can be segmented into regions: North America, Latin America, Europe, Asia Pacific and Middle East & Africa. Europe is biggest market for the vaccines adjuvants in terms of revenue and is expected to continue to dominate the market due to the increasing prevalence of disease such as, cancer and infections. Vaccine adjuvants market is expected to grow significantly in North America also, as FDA has added few of adjuvant containing vaccines in their stockpile. Asia Pacific and Africa is expected to be fastest growing vaccine adjuvants market over the forecast period due to increasing prevalence of cancer, HIV, influenza, hepatitis and others. Increasing population is also a growth factor the vaccine adjuvants market. Focus of the WHO and governments to curb the various disease is also boosting the growth of vaccine adjuvants market.
Vaccine Adjuvants Market: Key Players
Some of the key players in the global vaccine adjuvants market are, InvivoGen, OZ Biosciences, Sigma-Aldrich Co. LLC, SEPPIC, SPI Pharma, Agenus, Inc., Aphios Corp, VaxLiant LLC, Vaxine Pty Ltd and Kineta, Inc. Top companies are focusing on the merger and acquisition strategies to expand into new regions.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
The report covers exhaustive analysis on:
Regional analysis includes
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.